Corcept Therapeutics Inc
CORT· Nasdaq
Released May 5, 2025, after the close
10-Q filed May 5, 2025, 35 days after period end · 0001628280-25-022173
| Metric | Q1 2025 | Q1 2024 | Q1 2023 | Q1 2022 |
|---|---|---|---|---|
| Revenue | $157.21M | $146.81M | $105.65M | $93.69M |
| Net Income | $20.55M | $27.76M | $15.88M | $22.80M |
| EPS Diluted |
Corcept Therapeutics Inc · CIK 1088856 · Engraved from SEC EDGAR
| $0.17 |
| $0.25 |
| $0.14 |
| $0.20 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.